Biocorp: simplified tender offer opened on September 7
As a reminder, the Danish pharmaceutical company has irrevocably undertaken to acquire, at a unit price of 35 euros, all the 1,094,726 shares it does not already own, representing 24.81% of the company's capital and 24.72% of its voting rights.094,726 shares it does not hold, representing 24.81% of the share capital and 24.72% of the voting rights of this company.
It intends to request, at the end of the offer period, and if the required conditions are met, the implementation of a squeeze-out for Biocorp shares not tendered to the offer, at the same price.
Copyright (c) 2023 CercleFinance.com. All rights reserved.
Go to the original article.
Contact us to request a correction